Delivery Order SPE2DB25D3012-SPE2DB26FWVPC
Award Date 10/21/25
Potential Completion Date 10/22/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,874.60 to AmerisourceBergen Drug Corp for VIMPAT 10 mg/mL solution in a 200 mL quantity. This contract, which was competitively awarded without a set-aside designation, represents a firm fixed price delivery order with an ultimate completion date of August 27, 2025. VIMPAT (lacosamide) is an antiepileptic medication used to treat partial-onset seizures, reflecting the critical pharmaceutical supply needs of federal military and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,689.20 to AmerisourceBergen Drug Corp for VIMPAT 200 mg tablets (60-count supply). This competitive, non-set-aside contract was awarded on September 25, 2025, with an ultimate completion date of September 26, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, under firm fixed-price terms. This delivery order is a child contract issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VIMPAT 100 MG TABLET 60S for a total ceiling value of $1,484.97. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of VIMPAT 200 mg/20 ml vials valued at $1,365.00. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of VIMPAT 10 mg/mL solution in 200 mL quantities, valued at $1,959.86. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and will...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for VIMPAT 10 mg/mL solution in 200 mL quantities, valued at $1,322.67, with a completion date of September 9, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.04 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of VIMPAT 10 mg/ml Solution in 200ml quantities. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. VIMPAT (lacosamide) is a prescription anticonvulsant medication used in the treatment of...
- The Defense Logistics Agency awarded a delivery order valued at $3,707.00 to AmerisourceBergen Drug Corp for the supply of VIMPAT 100 mg tablets (60-count units). This contract, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of VIMPAT 150 mg tablets (60-count units) with a ceiling value of $2,892.26. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by September 23, 2025, and will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $1,455.99 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for VIMPAT 10 mg/mL Solution in 200 mL quantities. This firm fixed price order, with an ultimate completion date of August 4, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was awarded without a set-aside designation through competitive procurement, and performance will occur at the...